Nicole Siniscalco

Executive Neuroscience Sales Specialist

Role: Executive Neuroscience Sales Specialist at Acadia Pharmaceuticals
Location: New Brunswick, NJ, US
LinkedIn followers: 500 followers

Sales & Business DevelopmentView LinkedIn profile

About Nicole Siniscalco

5X Circle of Excellence awards, highly accomplished, results driven specialty sales account manager with significant experience in pharmaceutical sales and AI powered behavioral prediction platforms. Utilizes clinical data, competitive knowledge, consultative and compliant approaches to drive sales in Rare disease, Dermatology, Nephrology, Podiatry and Immunology.20••••23 Ranked in Top 10 TRx Rare Renal Disease TRx Sales Leader at Otsuka20••••19 President\'s Club (2019) Ranked in Top 10 TRx Leader Sales Specialist at PharmaDerm/Novartis 2013, 2014 President\'s Club Member at Taro Pharmaceuticals USA2009, 2010 President\'s Club Member at Tiber LaboratoriesSpecialties: Omnichannel analytics/Targeting, Marketing/Developing Product Launch StrategiesExperience with Ecosystem Matrix Teams CET (Customer Engagement Transformation)REMS Program Certification

Experience

Executive Neuroscience Sales Specialist
Acadia Pharmaceuticals
Jan 2026 — Present · New Brunswick, NJ, US

Education

Long Island University
BA, Psychology
Monmouth University
MA, Clinical Psychology

Skills

Acne
Psychiatry
New Business Development
Sales Management
Dermatology
Sales Force Development
Pharmaceutical Sales
Pediatrics
Pharmaceuticals
Psoriasis
Account Management
Coaching
Product Launch
Asthma

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@acadia.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Acadia Pharmaceuticals

Pharmaceutical Manufacturing · 1K employees · San Diego, California, United States

At Acadia, our mission is to turn scientific promise into meaningful innovation that makes the difference for underserved neurological disorders and rare disease communities around the world. Our commercial portfolio includes FDA-approved treatments for Parkinson's disease psychosis and Rett syndrome. We are developing the next wave of therapeutic advancements with a robust and diverse pipeline that includes mid- to late-stage programs in Alzheimer's disease psychosis and Lewy body dementia psychosis, along with early-stage programs that address other unmet patient needs.

acadia.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.